Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

Dual action weight loss in IIH - IIHDUAL Ended

2024-517120-19-02 Idiopathic Intracranial Hypertension 6 2022-09-02
N/A Ended

2024-515090-96-00 Thyroid Eye Disease 11 2022-05-10
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Ended

2023-508571-37-00 Geographic atrophy (GA) secondary to Age-related Macula 4 2022-04-29
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects with Geographic Atrophy Secondary to … Ended

2024-512945-18-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2021-11-30
Evaluation of the efficacy and safety of topical treatment on clinical signs and symptoms of dry eye disease associated with moderate meibom… Ended

2024-518093-13-00 Dry Eye and Meibomian Gland Dysfunction 6 2021-10-26
A clinical study of OPT-302 with ranibizumab compared to ranibizumab alone in patients with neovascular age-related macular degeneration Ended

2024-512879-13-00 Neovascular age-related macular degeneration (wet AMD) 5 2021-09-23
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
Spontaneous Retinal Arterial Pulsations (SRAPs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVOs) in patients treated o… Ended

2024-516681-10-01 central retinal vein occlusions 4 2021-03-24
Extension study to evaluate the long-term outcomes of subjects in study 20090 Ended

2023-504207-89-00 Retinopathy of prematurity 5 2020-03-27
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertensi… Ended

2023-504601-36-00 Open-angle Glaucoma 5 2019-11-20
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the … Ended

2023-509134-19-00 Myopia 5 2019-10-23
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension Ended

2022-502380-37-00 Open-Angle Glaucoma 5 2019-08-02
Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy. (SNAP) Ended

2024-511820-15-03 Medically uncontrolled glaucoma that requires filtratio 6 2019-08-01
Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1 Ended

2024-511885-35-00 macular telangiectasia type 1 5 2019-07-03
Explore the safety and efficacy of subretinal administration of CPK850 gene therapy in patients with retinitis pigmentosa caused by mutation… Ended

2023-508688-54-00 Retinitis pigmentosa caused by biallelic mutations in t 7 2018-08-22
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in th… Ended

2024-511687-90-00 retinitis pigmentosa 7 2017-10-12
Neovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroid melano… Ended

2024-513746-11-00 Patient with large choroid melanoma 7 mm thick and/or m 5 2017-06-08
OXU-001 compared to Intravitreal Ozurdex for the Treatment of Diabetic Macular Edema Ended

2023-503496-17-00 Diabetic Macular Edema (DME) 4
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i… Ended

2024-512986-15-00 Sjögren’s Disease 4
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio… Ended

2023-509206-29-00 Neovascular age-related macular degeneration (nAMD) 5